SEC Form D · filed October 31, 2016
CURE PHARMACEUTICAL Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Rob Davidson · Oxnard, CAExec · DirectorWayne Nasby · Oxnard, CADirectorVic Branstetter · Oxnard, CADirectorMark Udell · Oxnard, CAExecEd Maliski · Oxnard, CADirectorIan Sephton · Oxnard, CADirectorLuke Ledbetter · New York, NYDirectorPatrick Hutchines · Luxembourg, LuxembourgExecAlex Maffeo · New York, NYDirectorAndrew Lerner · New York, NYExec · DirectorVic Branstetter · Oxnard, CADirectorCarle D. Stenmark · San Francisco, CADirectorBob Glosson · Durham, NCExec · DirectorBarry Boniface · Durham, NCDirectorJerry Nowlin · Durham, NCDirectorMark Feidler · Durham, NCDirectorJack Barry · Durham, NCExecJohn L. King, Jr · Fort Worth, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗